|Articles|April 9, 2015

New Role for Former FDA Commissioner Hamburg

FDA commissioner Margaret Hamburg has received praise and plaudits as she exits the Food and Drug Administration this week after six years on the job.

 

Former FDA commissioner Margaret A. (Peggy) Hamburg has been appointed as the next foreign secretary of the Institute of Medicine (IOM), the health arm of the National Academy of Sciences. In the part-time position, Hamburg will serve as a senior adviser on international matters to the IOM president and council and as liaison to foreign academies of medicine and science.  According to NAS, Hmaburg's term began April 6 and is effective through June 30, 2019.

"Global engagement and impact are strategically important for the IOM.  I am delighted that Peggy has agreed to take on this important responsibility," said IOM president Victor J. Dzau.  Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public


Related to this article

How QMM Can Help the C-Suite See a  $100 Million Problem Early
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.